Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine added to mood stabilizers for bipolar depression
IRCT20101130005280N58Phase 4Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ketamine in bipolar disorder (BD) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Depression and Hamilton Depression Rating Scale. Started Oct 2022; status: completed.
02
Drugs
ketamine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on IRCT20101130005280N58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101130005280N58.